Recent Finacing
Recent Raise
Apeliotus develops the AdaptDx, an FDA‑approved computer‑automated dark adaptometer that measures patients' dark adaptation over a 20‑minute test to detect early age‑related macular degeneration.
This company doesn't have industry or investor information available.
Total Raised
Funding round